Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +35.02%
#3 Fabric Protocol Fabric Protocol +30.68%
#4 Nockchain Nockchain +19.84%
#5 Cysic Cysic +19.17%
#6 Bedrock Bedrock +18.72%
#7 Perle Perle +11.77%
#8 The Black Bull The Black Bull +10.40%
#9 FOLKS FOLKS +7.85%
#10 Epic Chain Epic Chain +7.11%
Coin of the day
EXOD EXOD
設定
言語
日本
通貨
USD
テーマ
Sirona Biochem Corp. Sirona Biochem Corp.

Sirona Biochem Corp.

SRBCF
株式のランク #37537
Sirona Biochem Corp. operates as a biotechnology company dedicated to... Sirona Biochem Corp. operates as a biotechnology company dedicated to uncovering and commercializing active ingredients for both cosmetic and pharmaceutical uses, with a commercial presence in Canada and France. Key initiatives include the development of a cosmetic skin brightener and a pharmaceutical solution for diabetes. Beyond these, the company is engaged in several other projects, such as building a library of anti-aging and cell-protective compounds, creating a novel anti-wrinkle agent, and pursuing an antiviral research program. A notable collaboration exists with the International Centre for Genetic Engineering and Biotechnology (ICGEB) for the joint development of an antiviral compound library. Established in 2006, the business, originally named High Rider Capital Inc., rebranded as Sirona Biochem Corp. in May 2009 and maintains its headquarters in Vancouver, Canada.
株価
$0.0051
最終同期: 2026-08-13
時価総額
$1.63M
変化（1日）
0.00%
変化（1年）
-60.31%
国
CA
取引 Sirona Biochem Corp. (SRBCF)

カテゴリー

Healthcare
Sirona Biochem Corp.（SRBCF）の利益
2026 時点の利益 TTM: 0
Sirona Biochem Corp. の最新の財務報告によると、同社の現在の利益は 0 です。2026 年には 0 の利益を上げ、これは 2026 年の利益 0 と 同等 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Sirona Biochem Corp. の利益の推移（2026 〜 2026）
各年末の利益
年 利益 変化
提供された日付のデータは十分ではありません。
同業他社の利益
企業 利益 利益の差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE